Status:
COMPLETED
Verification of the Reliability and Validity of THINC-it Tool in Bipolar Depression
Lead Sponsor:
Shanghai Mental Health Center
Conditions:
Bipolar Depression
Eligibility:
All Genders
18-65 years
Brief Summary
There is some cognitive impairment in patients with bipolar depression. THINC-it is a simple, fast and free cognitive assessment tool. It has good reliability and validity in patients with depression,...
Detailed Description
There is some cognitive impairment in patients with bipolar depression. THINC-it is a simple, fast and free cognitive assessment tool. It has good reliability and validity in patients with depression,...
Eligibility Criteria
Inclusion
- Case group:
- Participants in psychiatric outpatients and inpatients are able and willing to provide informed consent.
- two。. The participants were male or female aged between 18 and 65, with junior high school education or above.
- 3\. According to DSM-5 criteria, participants were diagnosed with depressive episodes of bipolar disorder.
- 4\. The total score of Young's Mania scale ((YMRS)) of the participants was less than 5.
- 5\. Subjects received stable mood stabilizers at least two weeks before the study visit, such as SSRIs antidepressants.
- 6\. The combination or use of supportive psychotherapy is allowed.
- Control group:
- it did not meet any of the diagnostic criteria of axis I in DSM-5 in the past or at present.
- 18-65 years old, junior high school education or above. 3.have sufficient audio-visual skills to complete the necessary examinations of the study.
- Willing to participate in this study, and the informed consent form was signed by the subjects.
Exclusion
- Current alcohol and / or substance use disorders.
- Any drug that may affect cognitive function, such as psychotropic stimulants, corticosteroids, and receptor blockers.
- Benzodiazepines were used within 12 hours and alcohol consumption within 8 hours before using the THINC-it cognitive test.
- The patient has some serious physical conditions.
- The patient received electroconvulsive therapy ((ECT)) in the past 6 months.
- There are serious negative suicidal concepts and behaviors.
Key Trial Info
Start Date :
July 5 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2021
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04471454
Start Date
July 5 2020
End Date
September 30 2021
Last Update
October 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Mental Health Center IRB
Shanghai, Shanghai Municipality, China, 200030